جستجوی استاد راهنمای دانشگاهی

Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.

• Clinical Toxicology
• Pharmacoepidemiology
• Poisoning
• +۳ مورد دیگر

Suzanne Estaphan is a Senior Lecturer in Medical Science (Physiology and Clinical Pharmacology) at the Australian National University (ANU) School of Medicine and Psychology . She holds qualifications including a Doctorate of Physiology (2015) , MSc in Physiology (2012) , MBBCh (2005) , and Basic Certificate in Medical Education (2018) . Her academic roles span curriculum development, admissions, and assessment committees in the ANU Medical School. Senior Lecturer, ANU (2023–present) Academic Editor, PLOS ONE (2024–present) Review Editor, Frontiers in Physiology (2023–present) Dr. Estaphan's research bridges oxidative stress and inflammation in disease pathology with medical education innovation . Her work explores antioxidant interventions for organ damage and investigates AI/virtual reality applications in education. Recent projects include studying sleep dysfunction in eating disorders and diabetes medication effects on exercise capacity . Between 2023–2025, her 15 most recent publications span oxidative stress , medical education , and molecular pathophysiology . Themes include homeostasis , clinical reasoning , and metabolic disorders , with subfields like MMP-9 biology , pancreatic injury , and VR-based hypoxia training . Scientific accolades include the American Physiological Society Travel Award (2017) and recognition as Senior Fellow of the Higher Education Academy (2023) . She mentors medical students, contributes to national physiology curriculum consensus projects, and has secured approximately $200,000 in research funding .

• Medical Physiology
• Oxidative Stress and Inflammation
• Medical Education Research
• +۲ مورد دیگر

Associate Professor Aditi Dey holds a conjoint appointment at the Sydney Medical School within the University of Sydney , and serves as Manager of Surveillance at the National Centre for Immunisation Research and Surveillance (NCIRS) . Her work focuses on immunization program evaluation, vaccine coverage analysis, and surveillance of vaccine-preventable diseases and adverse events. She has extensive experience in public health research, spanning roles in Thailand and India prior to her current positions in Australia. Dr Dey completed an MBBS, followed by postgraduate qualifications including a DTM&H (Tropical Medicine & Hygiene), Grad Dip Applied Science (Health Information Management), MPH, and a PhD from the University of Sydney. Her research integrates epidemiological analysis with public health policy implementation, particularly addressing health disparities in vaccination access and outcomes among Indigenous populations and other underserved groups. Her research interests prominently feature vaccine safety , epidemiological trends of infectious diseases, and the impact of vaccination policies such as Australia’s “No Jab, No Pay” initiative. She also investigates the effectiveness of vaccination programs for diseases like rotavirus, HPV, and varicella-zoster virus, often analyzing large-scale national health datasets. Notable contributions include evaluations of Australia’s HPV vaccination program, analysis of rotavirus vaccine efficacy, and assessments of adverse events following immunization. Her work emphasizes improving immunization coverage through better data systems and healthcare provider education, particularly for at-risk populations. Dr Dey actively contributes to public health efforts through teaching and course coordination at the University of Sydney, and collaborates with institutions like the Sydney Infectious Diseases Institute . Her expertise bridges clinical practice, research, and policy, driving evidence-based improvements in Australia’s immunization landscape.

• Epidemiology
• Public Health
• Child Health
• +۵ مورد دیگر

Professor Mark Morrison is an Affiliate Professor at the School of Chemistry and Molecular Biosciences, University of Queensland, and holds roles as Chair & Group Leader of Metagenomics at the Frazer Institute within the Faculty of Health, Medicine and Behavioural Sciences. His research focuses on clinical microbiology, gastroenterology, and the microbiome’s role in diseases like inflammatory bowel disease (IBD) and diabetes. He has extensive academic qualifications, including a Bachelor of Science from the University of New South Wales, a Master’s from James Cook University, and a PhD from the University of Illinois. Education : Bachelor of Science, University of New South Wales Masters (Research) of Science, James Cook University Doctor of Philosophy, University of Illinois His research interests span microbiome-driven health and disease mechanisms, particularly in gut-brain interactions, mucosal microbiota dynamics, and translational therapies. Over 390 works include studies on dietary FODMAP effects, microbiome-based IBD diagnostics, and SCFA therapy for diabetes. He leads interdisciplinary grants on microbiome manipulation and has advised numerous PhD students on topics like Crohn’s disease, archaeal biodiversity, and immune modulation. His recent articles highlight microbiota roles in SIBO, anastomotic leaks, and probiotic efficacy. While no explicit awards are cited, his contributions to gut microbiome science are recognized through active research collaborations and funding. He actively supervises students and chairs teams advancing metagenomics and clinical applications.

• Biomedical and Clinical Sciences
• Clinical microbiology
• Gastroenterology and hepatology
• +۳ مورد دیگر

Associate Professor Abdul Ihdayhid is a Research Leader in Cardiovascular Biology at the Curtin Medical School , Curtin University, within the Faculty of Health Sciences. His work focuses on advanced cardiac imaging techniques, particularly coronary CT angiography, fractional flow reserve modeling, and AI integration in cardiovascular diagnostics. Key Research Areas: Cardiovascular imaging, artificial intelligence applications, aortic stenosis interventions, and ethical implications of AI in medicine. Recent Publications: Analysis of high-risk coronary plaque, telehealth adaptations during pandemics, and AI-driven CAC scoring innovations. Collaborations: Extensive partnerships with institutions across Australia and New Zealand on multicenter studies like the Australian-New Zealand SCAD cohort. His 2024-2025 work emphasizes machine learning for plaque quantification and ethical frameworks in AI implementation. Email: Abdul.Ihdayhid@curtin.edu.au

• Cardiovascular Medicine
• Cardiac Imaging
• Artificial Intelligence in Cardiology
• +۳ مورد دیگر

Tanya Golubchik is a Senior Lecturer in Computational Microbiology and an NHMRC Principal Research Fellow at the University of Sydney's School of Medical Sciences under the Faculty of Medicine and Health. She is affiliated with the Sydney Southeast Asia Centre and the Sydney Infectious Diseases Institute (Sydney ID). Her research focuses on applying modern genomics technologies to study pathogen evolution and transmission, particularly in viruses and bacteria with public health significance. She has collaborated extensively with institutions such as the University of Oxford's Big Data Institute and the PANGEA-HIV Consortium, contributing to HIV and SARS-CoV-2 genomic analysis. Educated at the University of Sydney with a dual major in biology and computer science, she earned her PhD in molecular biology. Her postdoctoral work at the University of Oxford involved pneumococcal vaccine escape variants and within-host bacterial evolution. She led computational analysis of SARS-CoV-2 sequencing during the pandemic as part of the COG-UK Consortium and returned to Sydney in 2022. Her research interests include understanding how pathogens evolve within hosts, develop strategies to combat infections, and integrate metagenomics for clinical insights. She has pioneered methods like targeted metagenomics for simultaneous sequencing and transcriptional profiling of pathogens. Recent work examines RSV intrahost diversity in infants and SARS-CoV-2 transmission dynamics in the UK. She also explores climate change impacts on disease through CLIMADE and investigates HIV transmission networks in Africa. Her scientific contributions include the 2023 Thompson Prize from the University of Sydney. Research grants span projects like genomics solutions for HIV surveillance in low-income settings, vector-borne disease detection amid climate change, and metagenomic studies in female reproductive health. Her work bridges epidemiology, genetics, and translational research, emphasizing interdisciplinary approaches to global health challenges. In advising and grants, she has secured funding for high-throughput sequencing and transmission network analysis. While no formal advisee names are listed, her supervisory roles in molecular epidemiology and bioinformatics suggest active student mentoring. Collaborations with international teams and institutes highlight her global engagement in addressing infectious disease threats through computational and genomic strategies. Key teams include the PANGEA-HIV Consortium, COG-UK, and CLIMADE. She leads initiatives at Sydney ID and the School of Medical Sciences, advancing pathogen genomics and outbreak response methodologies.

• Pathogen Genomics
• Virus Diseases
• Bacterial Evolution
• +۷ مورد دیگر

Yi-Chin Toh is a Professor in the Faculty of Engineering at Queensland University of Technology (QUT), leading the Micro Tissue Engineering Lab. She holds an ARC Future Fellowship and has held prior roles as an Assistant Professor at the National University of Singapore. Her expertise lies in microfluidic tissue models for drug testing and organ-on-a-chip technologies. She earned her B.Eng. (2001) and Ph.D. (2008) in Bioengineering from National University of Singapore, followed by postdoctoral training at MIT and A*STAR. Her research focuses on advancing alternative animal-free technologies, with notable contributions to multi-organ microfluidic platforms and 3D bioprinted tissue models. She has published over 70 peer-reviewed articles, secured eight patents, and received accolades like the 2022 Lab on a Chip Pioneers in Miniaturization Award and 2019 Global 3R Award. She holds editorial roles in journals like Biomicrofluidics and contributes to conferences such as MicroTAS. Key research areas include mechanobiology modeling, hepatic-microbiome interactions, and AI-driven single-cell analysis. Her lab’s work bridges academia and industry, emphasizing translational applications in drug safety and toxicology. Current projects include modular microfluidic platforms for multi-organ interactions and FDA-regulatory compliant non-animal testing systems. Education: B.Eng in Chemical Engineering, National University of Singapore (2001) Ph.D. in Bioengineering, National University of Singapore (2008) Awards & Leadership: Lab on a Chip Lectureship (2022), Global 3R Award (2019), ARC College of Experts member, and leadership roles in MicroTAS conferences. She also leads the ARC Training Centre for Cell and Tissue Engineering Technologies.

• Biomedical Engineering
• Microfluidics
• Tissue Engineering
• +۴ مورد دیگر

Dr Christine Staatz is an Associate Professor at the University of Queensland 's School of Pharmacy and Pharmaceutical Sciences , specializing in Quality Use of Medicine and Pharmacometrics . Her career spans both clinical pharmacy practice and academic research, with international experience at the University of Glasgow and Uppsala University. B.Pharm (Hons I), University of Queensland (1996) PhD, University of Queensland (2002) Pharmacist registration: Australia (1997), UK (2003) Her research focuses on individualized drug therapy for transplant recipients and critically ill patients, particularly optimizing immunosuppressants (tacrolimus, mycophenolate) and antibiotics (beta-lactams, gentamicin). Recent publications examine age-related pharmacokinetics and microsampling techniques to reduce patient burden. Key contributions include 15+ peer-reviewed articles in 2024-2025 addressing: Bayesian forecasting of drug exposure Free vs total plasma drug concentrations Time-dependent clearance in pediatric chemotherapy Immune-related adverse effects in transplant recipients NHMRC Neil Hamilton Fairley Fellowship (2004) Lions Medical Research Fellowship National grants exceeding AUD$2 million With 14+ completed PhD/MPhil supervisees and ongoing projects in autoimmune diseases and hematopoietic transplantation , she actively mentors students in clinical pharmacology and drug monitoring research.

• Quality Use of Medicine
• Pharmacometrics
• Transplant Pharmacology
• +۳ مورد دیگر

Tony Tiganis is a Professor in the Department of Biochemistry and Molecular Biology at Monash University, where he also serves as Laboratory Head and leads the Metabolism, Diabetes and Obesity Program at the Monash Biomedicine Discovery Institute. He holds a joint appointment as Laboratory Head at the Peter MacCallum Cancer Centre and is an Adjunct Professor at Yale School of Medicine. His multidisciplinary research focuses on protein-tyrosine-phosphatases (PTPs) and their roles in metabolism, cancer, and immunity. Ph.D. in Biochemistry, University of Melbourne (1990–1994) B.Sc. (Hons) in Pharmacology, University of Melbourne (1986–1989) Professor Tiganis’s research centers on tyrosine-phosphorylation-dependent signaling, with a focus on PTPs. His work has challenged long-standing misconceptions about PTPs being 'undruggable' and has revealed their critical roles in obesity, type 2 diabetes, cancer, and immune regulation. His lab has made seminal contributions to understanding redox balance in metabolic health, T cell tolerance mechanisms, and central control of energy balance. These discoveries have significant translational potential, including intranasal therapies for obesity and genetically engineered CAR T cells for solid tumors. His recent publications span high-impact journals such as Journal of Clinical Investigation , Nature Communications , and Cell Metabolism , highlighting trends in redox signaling, immunometabolism, and therapeutic targeting of PTPs in cancer and metabolic disease. His work is frequently cited and has garnered attention from news outlets, social media, and the pharmaceutical industry. Melbourne University Postgraduate Scholarship (1990) C.J. Martin Fellowship, NHMRC (1995) AMRAD Post-Doctoral Award (1998) St. Vincent’s Hospital Research Week, Senior Investigator Prize (1999) Deans Award in Excellence in Research (2009) NHMRC Principal Research Fellowships (2010–2015, 2016–2020) Tony Tiganis actively supervises PhD students and leads multiple research projects funded by the National Breast Cancer Foundation and Cancer Council Victoria. He serves as an editor for FEBS Journal , Molecular & Cellular Biology , and Science Advances . His lab operates the Monash Metabolic Phenotyping Facility and collaborates with clinicians and chemists on translational programs. He is also a Scientific Advisory Board Member at DepYmed Inc. and a Consultant for Regeneron Pharmaceuticals. He leads a multidisciplinary team exploring the intersection of metabolism, immunity, and cancer, with ongoing projects investigating the impact of obesity on anti-tumor immunity and phosphatase roles in cancer pathogenesis.

• Cell Signalling
• Protein Tyrosine Phosphatases (PTPs)
• Obesity
• +۱۲ مورد دیگر

Fabio Luciani is a Professor in Systems Immunology and Machine Learning at the School of Medical Sciences at UNSW Sydney, with visiting fellow positions at the Garvan Institute for Medical Research and Weill Cornell College of Medicine NY, USA. His interdisciplinary research program integrates immunology, genomics, and computational approaches to develop novel immunotherapies for cancer and autoimmune diseases. With a background spanning physics, theoretical biology, and biophysics, Luciani leads an interdisciplinary team with expertise in immunology, mathematical modeling, statistics, and bioinformatics. His research focuses on T cell responses using single-cell genomic technologies to understand immune responses in viral infections, autoimmunity, and CAR T cell therapies. He has developed landmark bioinformatic methods for combining single-cell transcriptome data with antigen receptor sequences and computational models for haplotype reconstruction. Luciani's work demonstrates a strong emphasis on translating molecular and genomic discoveries into clinical interventions, particularly in predicting side effects and identifying solutions for unmet clinical needs in immunotherapy. His research spans multiple collaborative projects including single-cell multi-omics analysis in coeliac disease with Prof Chris Goodnow's team at the Garvan Institute, and CAR T cell therapy response studies with clinicians at Westmead Hospital and Weill Cornell. His scientific contributions include over 140 peer-reviewed publications and successful acquisition of more than $20 million in research funding from organizations including ARC, NHMRC, JDRF, NIH, and private industry partners. He serves as Principal Investigator of the UNSW Future Institute of Cellular Genomics, which has secured $4.5 million over seven years for single-cell technologies in cellular genomics. As an academic supervisor, Luciani currently mentors 3 PhD students, 2 honours students, and 2 postdoctoral researchers, welcoming applications from students interested in bioinformatics, statistics, data science, immunology, and genomics. His work bridges theoretical approaches with experimental immunology to advance precision medicine and transform current immunotherapies into more precise and accessible solutions.

• genomics
• immunology
• computational biology
• +۶ مورد دیگر

Associate Professor Patrick Bertolino at the University of Sydney's Central Clinical School leads the Liver Immunology Program at the Centenary Institute. With 20+ years of international recognition in liver immunology , he pioneered discoveries about CD8+ T cell activation and hepatocyte-mediated immune tolerance , including the paradigm-shifting finding that liver-activated T cells are deleted via hepatocyte lysosomes. His work bridges transplantation immunology , chronic hepatitis , and malaria vaccine development using transgenic mouse models . Trained by immunology luminaries: Chantal Rabourdin-Combe (ENS-Lyon), Jacques Miller (WEHI), Barbara Fazekas de St Groth (Centenary Institute) Continuous NHMRC funding since 2000: 2 Program Grants, 6 Project Grants 2010 NHMRC Senior Research Fellowship Research Themes explore how the liver uniquely regulates immunity: Induces transplant tolerance via T cell deletion Exploits immune subversion in hepatitis B/C and malaria Develops gene therapy and mRNA vaccines for liver-targeted immunity Investigates hepatitis C reinfection post-transplant Article Trends show sustained focus on T cell-liver interactions , with recent work on mRNA vaccines (2023), neuroinflammation in GVHD (2024), and long-lived TRM cells in malaria (2025). Publications span high-impact immunology , hepatology , and transplantation journals . Awards include: 2010 NHMRC Senior Research Fellowship 2009 Centenary Institute student paper award 1999 Kevin Lafferty Prize for Autoimmunity 1997 University of Sydney U2000 Fellowship Teaching includes 3rd-year Immunology lectures (since 1998). Led liver immunology group since 2011, mentoring students and postdocs. Collaborates with Centenary Institute and National Hepatitis C Elimination Program .

• Liver Immunology
• Immune Tolerance
• Transplant Immunology
• +۵ مورد دیگر

Stuart Roberts is an Adjunct Clinical Professor in the Department of Gastroenterology at Monash University, Faculty of Medicine, Nursing and Health Sciences. He is actively engaged in clinical research focusing on liver diseases, with a strong emphasis on chronic viral hepatitis, primary liver cancer, non-alcoholic fatty liver disease (NAFLD/MASLD), and non-invasive liver diagnostics such as Fibroscan. University: Monash University School: Faculty of Medicine, Nursing and Health Sciences Department: Department of Gastroenterology Academic Rank: Adjunct Clinical Professor His research interests center on advancing therapeutic strategies for chronic liver diseases through clinical trials and translational studies. Key areas include evaluating novel antiviral and immunomodulatory agents for hepatitis B and C, assessing new treatments for hepatocellular carcinoma, and investigating metabolic and dietary influences on liver health in aging populations. He also studies the role of liver stiffness measurement in disease screening and prognosis. The recent publications and active research projects (2024–2025) reflect a strong trend toward understanding the intersection of liver disease with aging, cardiovascular health, and neurocognitive outcomes. His work increasingly focuses on metabolic dysfunction-associated steatotic liver disease (MASLD), its systemic complications, and lifestyle or pharmacological interventions. Multiple phase 1 to phase 3 clinical trials are underway, particularly in NASH/MASH, hepatitis B immunotherapy, and cholangiocarcinoma. Scientific Awards: No awards mentioned in the provided text. Advising and Grants: Dr. Roberts serves as Primary Chief Investigator on 42 research projects, including major industry-sponsored clinical trials in hepatology. His leadership in multicenter studies highlights his role in shaping evidence-based liver disease management. While no formal student advising is mentioned, his collaborations involve trainees and junior researchers. Funding appears to come from pharmaceutical sponsors and institutional sources, supporting trials in antiviral, metabolic, and oncologic liver therapies. Labs and Research Teams: Dr. Roberts leads a clinical research team focused on hepatology within Monash Health. His work is highly collaborative, involving dietitians, oncologists, geriatricians, and neurologists. The research network includes national and international partners, with a strong presence in Australian multicenter liver disease studies.

• Hepatology
• Chronic Viral Hepatitis
• Primary Liver Cancer
• +۹ مورد دیگر

Xiaonan ZHANG is an Associate Professor in the Faculty of Science and Technology at the University of Canberra, leading the Hepatitis B Virus (HBV) Group within the Centre for Research into Therapeutic Solutions. He holds a PhD from Fudan University (2012) and previously worked at the Shanghai Public Health Clinical Centre until 2021. His research focuses on HBV molecular pathogenesis, therapeutic vaccine development, and next-generation sequencing applications in viral infections. His work has advanced understanding of HBV’s clinical outcomes, including the discovery of Capsid-Antibody-Complexes (CACs) and their role in pathogenesis. Collaborations span institutions like the Peter Doherty Institute, University of Queensland, and international partners such as Fudan University and University of Duisburg-Essen. Key projects include: Development of therapeutic mRNA vaccines for chronic HBV Clinical evaluation of CAC assays in HBV/HIV co-infections Metagenomic sequencing for pathogen identification Research interests emphasize translational medicine, with contributions to H7N9 influenza and SARS-CoV-2 studies during the pandemic. His team pioneered real-world analyses of viral and host factors in COVID-19 outcomes. Current focus includes liver-resident immune cell dynamics and novel diagnostic assays for HBV nucleic acids. Publications highlight innovations in HBV cccDNA tracking, immune complex mechanisms, and exosome-mediated signaling. No scientific awards were explicitly listed in the provided texts. Xiaonan actively collaborates on grants and supervises PhD students, advancing interdisciplinary approaches to viral diseases.

• Virology
• Molecular Biology
• Translational Medicine
• +۴ مورد دیگر

Associate Professor Nathan Johnson is an academic in the Department of Exercise and Sport Science at the University of Sydney's Faculty of Health Sciences. His research focuses on the interaction between physical activity and fat metabolism in health and disease, particularly in managing obesity, diabetes, and cardiovascular disease. He teaches undergraduate exercise science and postgraduate exercise physiology, emphasizing practical skill mastery and evidence-based clinical practice. Johnson holds degrees including a BMedSc, Master of Health Science (Hons), and PhD. He is a member of the Charles Perkins Centre and collaborates with institutions like Shanghai Jiao Tong University, CSIRO, and the Garvan Institute. His work is multidisciplinary, involving endocrinology, hepatology, and radiology. Research interests include developing exercise-based solutions for metabolic health without weight loss, targeting dangerous body fats. Key themes are Obesity, Diabetes and Cardiovascular Disease, and Healthy Ageing. His publications span journals like Diabetes Care , Journal of Hepatology , and British Journal of Sports Medicine . Johnson advocates for clinical exercise specialists as frontline fighters against metabolic diseases. His initiatives focus on training graduates to address obesity, diabetes, and cardiovascular challenges. He has led randomized controlled trials on exercise interventions and dietary regimens, emphasizing HIIT and low-volume training effects on liver fat and vascular health. His research also explores barriers to vigorous intermittent lifestyle physical activity (VILPA) and the role of exercise in improving quality of life for individuals with type 2 diabetes. Collaborations include studies on cannabidiol's effects on exercise physiology and the efficacy of mobile apps promoting physical activity.

• Exercise Physiology
• Metabolic Health
• Diabetes Management
• +۴ مورد دیگر

Dr Helen Parker is a Research Fellow in the Discipline of Exercise & Sport Science, School of Health Sciences, at the University of Sydney. Her work bridges nutrition, exercise science, and women's health. She holds a PhD (2015) and a Graduate Certificate in Educational Studies (2019), and is a Fellow of the Higher Education Academy. Her research explores body composition, omega-3 supplementation, gamified mobile apps for cardiac rehabilitation, and weight stigma in young women. Research trends from her 15 most recent publications (2025–2015) span cardiometabolic health, digital health interventions, obesity management, and behavioral nutrition. Key projects include the MyHeartMate gamification app and the everyBODY study targeting weight stigma. Scientific awards: Heart Foundation Vanguard Grant Rotary Mental Health Australia Funding Australia Nutrition Trust Fund Scholarship Multiple Higher Education and Research Society Awards She teaches in the Bachelor of Applied Science (Exercise & Sport Science, Exercise Physiology) and guest lectures across Physiotherapy, Nursing, and Nutrition programs. Active in professional societies including the Nutrition Society of Australia and Australian Cardiac Rehabilitation Association .

• Body Composition
• Nutrition
• Exercise Science
• +۵ مورد دیگر